Finalists on QF TV Show compete for share of $600,000 seed fund and status of Arab world’s top innovator

Doha, Qatar-Sunday 1 November 2020 [ AETOS Wire ]

Four inventors on Qatar Foundation’s Star of Science set themselves apart this season, overcoming challenges posed by COVID-19, and earning their places in the Grand Finale.  

In this week’s prototype testing episode, Ahmed Fathalla, Eiman Al Hamad, Mohammad Almogahwi, Sarah Aboerjaib, and Wadah Malaeb took to the stage to prove that their projects met consumer needs, conducting user testing on their inventions.

“These talented Arab youths overcame incredible odds to reach this point in Season 12; conceiving and constructing their inventions under challenging circumstances and the eye of a watchful jury has been inspiring,” said Khalid Al Jumaily, Stars of Science’s long-time host.

“Everyone on the show, from the contestants to the expert ... Read more »

RESTON, Va.-Saturday 31 October 2020 [ AETOS Wire ]

(BUSINESS WIRE) -- IDEMIA, a global leader in identity and security solutions and the number one provider of driver’s licenses in the U.S., today announced the development of a Converged Card solution in partnership with Mastercard, allowing cardholders to safely and securely shop for everyday essentials. The solution will help bring more people into the formal economy in the U.S. who currently have limited or no access to financial services.

Converged Card1 is a state-issued driver’s license or identification with a payment credential. This card or digital application will support state-subsidized programs, including unemployment benefits, housing and utility assistance, and tax refunds, allowing the government to automatically reach people that need funding through the public sector faster than with a paper check.

“This card will address the foundational issues of financial inclusion, all ... Read more »

• Three-way agreement among Takeda, Moderna and the Government of Japan’s Ministry of Health Labour and Welfare (MHLW) to bring Moderna’s COVID-19 vaccine candidate (mRNA-1273) to Japan

• Takeda will import and distribute 50 million doses of mRNA-1273 in Japan from the first half of 2021

• Adds to Takeda’s partnership to manufacture and supply Novavax’ COVID-19 vaccine in Japan

• Expands Takeda’s support of pandemic preparedness in Japan

OSAKA, Japan-Saturday 31 October 2020 [ AETOS Wire ]

(BUSINESS WIRE) -- Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK), announced today that it will import and distribute 50 million doses of Moderna’s COVID-19 vaccine candidate, mRNA-1273, starting in the first half of 2021, pending licensure in Japan. This effort is part of a three-way agreement among Takeda, Moderna and the Government of Japan’s Ministry of Health Labour and Welfare (MH ... Read more »

• DEUTSCHE BÖRSE LEADS FUNDING ROUND - CONDUCTED 100% REMOTELY DUE TO COVID-19

• COMPANY REPORTS RISING DEMAND DURING PERIOD OF SOCIAL UNREST AND VOLATILITY

NEW YORK-Saturday 31 October 2020 [ AETOS Wire ]

(BUSINESS WIRE) -- Clarity AI announced today that it has closed a USD $15 million funding round led by Deutsche Börse AG and co-investor Mundi Ventures. Clarity AI empowers investors to manage the impact of their portfolios through a proprietary technology platform that leverages big data and machine learning to assess sustainability for all societal stakeholders.

“Our purpose is simple: to measure the impact of companies on our society and planet,” said Rebeca Minguela, Founder and CEO of Clarity AI. “Investors attempting to evaluate impact have faced fragmented and unreliable data, inconsistent subjective definitions, and a lack of standards and tools for comprehensive analysis. Historically it has been too hard and re ... Read more »